Oryzon Genomics SA (ORY) — Free Cash Flow Generation Index

Latest as of December 2015: 1.17x

Oryzon Genomics SA (ORY) has a Free Cash Flow Generation Index of 1.17x as of December 2015. Free cash flow of €610.80K represents 1% of operating cash flow (€523.10K). See ORY net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.17x
Free Cash Flow / Operating CF

Free Cash Flow

€610.80K
EUR

Operating Cash Flow

€523.10K
EUR

Capital Expenditures

€87.70K
EUR

Oryzon Genomics SA Free Cash Flow Generation Index (2013–2015)

Historical FCF Generation Index trend for Oryzon Genomics SA across 3 annual periods. Explore cash flow to debt ratio of Oryzon Genomics SA to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Oryzon Genomics SA (2013–2015)

Year-by-year Free Cash Flow Generation Index for Oryzon Genomics SA. For the full company profile including market capitalisation, see Oryzon Genomics SA market capitalisation.

Year FCG Index Free Cash Flow (EUR) Operating CF Capital Expenditures YoY Change
2015 1.17x €610.79K €523.14K €87.65K ▲ +16.3%
2014 1.00x €12.17 Million €12.13 Million €47.00K ▼ 0.0%
2013 1.00x €12.17 Million €12.13 Million €47.30K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).